Company Description
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand.
Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
The company offers Dario Evolve, a metabolic solution to address metabolic health needs, such as diabetes, pre-diabetes, hypertension, and weight management; Dario Move, which address most common musculoskeletal conditions; Dario Elevate, a behavioral health solution that optimizes access to evidence-based care; and Dario One, a full suite of chronic condition management solution; and Dario blood glucose monitoring systems.
It also provides native devices, such as glucose meter, blood pressure cuff, digital scale, and biofeedback sensor device, as well as live coaching services.
The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016.
DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.
| Country | United States |
| Founded | 2011 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 276 |
| CEO | Erez Raphael |
Contact Details
Address: 322 W 57th St. #33b New York, New York 10019 United States | |
| Phone | 972-4-770-6377 |
| Website | mydario.com |
Stock Details
| Ticker Symbol | DRIO |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001533998 |
| CUSIP Number | 23725P209 |
| ISIN Number | US23725P2092 |
| Employer ID | 45-2973162 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Erez Raphael | Chief Executive Officer and Director |
| Richard A. Anderson | President |
| Zvi Ben David CPA | Chief Financial Officer, Treasurer and Secretary |
| Dov Oppenheim | Co-Founder and Production Chief |
| Tomer Ben-Kiki | Chief Operating Officer |
| Josh Fischer | Senior Vice President of Operations and Compliance |
| Claudia Levi | Content and Communications Manager |
| Mary Mooney | Vice President of Marketing |
| Limor Drezner | Chief People Officer |
| Jean Christophe Muyl | Head of Commercialization North America |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Apr 22, 2024 | S-3 | Registration statement under Securities Act of 1933 |
| Apr 22, 2024 | 8-K | Current Report |
| Apr 19, 2024 | PRE 14A | Other preliminary proxy statements |
| Apr 19, 2024 | 8-K | Current Report |
| Apr 19, 2024 | 424B3 | Prospectus |
| Apr 5, 2024 | 8-K | Current Report |
| Mar 28, 2024 | 10-K | Annual Report |
| Mar 1, 2024 | 8-K | Current Report |
| Feb 29, 2024 | D | Notice of Exempt Offering of Securities |
| Feb 22, 2024 | 8-K | Current Report |